WEBINAR: 2021 Predictions — The Rise Of AI Assisted Decentralized Clinical Trials

Register Now

AI has the ability to power meaningful virtual clinical trials that allow sites to objectively measure changes in patient behavior and symptoms. While decentralized clinical trial technologies were particularly important during the pandemic, many of these remote practices will stick — the odds that the industry will return entirely to trial designs heavily reliant on in-person clinical visits seems low.

Join Ed Ikeguchi for a fireside chat to learn more about his predictions for clinical trial technology in 2021 and beyond.


  • Ed Ikeguchi MD, Chief Executive Officer at AiCure
  • Lauren Sunshine, Director, Strategic Partnerships at AiCure (moderator)